Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novocol Pharma
Cambridge, Ontario, Canadanovocolpharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Novocol Pharma is an established Canadian contract development and manufacturing organization specializing in aseptic fill-finish for sterile injectables, including small molecules, peptides, and vaccines. The company has recently expanded its state-of-the-art facility to support both clinical and commercial production. It is recognized for strategic partnerships with global biopharma companies—including Moderna—for domestic vaccine supply chain security. No proprietary clinical results as it does not develop its own drugs
- Modalities
- Small moleculePeptidesVaccine
- Industry
- Contract Manufacturing Organization
02
Partnerships
Moderna (fill-finish agreement for mRNA vaccines)
Beyond the preview
Go deeper on Novocol Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novocol Pharma.